These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27275785)

  • 1. Further development of biomarkers in amyotrophic lateral sclerosis.
    Blasco H; Vourc'h P; Pradat PF; Gordon PH; Andres CR; Corcia P
    Expert Rev Mol Diagn; 2016 Aug; 16(8):853-68. PubMed ID: 27275785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    Mitropoulos K; Katsila T; Patrinos GP; Pampalakis G
    OMICS; 2018 Jan; 22(1):52-64. PubMed ID: 29356625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics in amyotrophic lateral sclerosis: how far can it take us?
    Blasco H; Patin F; Madji Hounoum B; Gordon PH; Vourc'h P; Andres CR; Corcia P
    Eur J Neurol; 2016 Mar; 23(3):447-54. PubMed ID: 26822316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From use of omics to systems biology: Identifying therapeutic targets for amyotrophic lateral sclerosis.
    Castelli L; Vasta R; Allen SP; Waller R; Chiò A; Traynor BJ; Kirby J
    Int Rev Neurobiol; 2024; 176():209-268. PubMed ID: 38802176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of neuroimaging as a biomarker in amyotrophic lateral sclerosis: from structure to metabolism.
    Sun W; Liu SH; Wei XJ; Sun H; Ma ZW; Yu XF
    J Neurol; 2024 May; 271(5):2238-2257. PubMed ID: 38367047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'Omics' of Amyotrophic Lateral Sclerosis.
    Caballero-Hernandez D; Toscano MG; Cejudo-Guillen M; Garcia-Martin ML; Lopez S; Franco JM; Quintana FJ; Roodveldt C; Pozo D
    Trends Mol Med; 2016 Jan; 22(1):53-67. PubMed ID: 26691296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging in amyotrophic lateral sclerosis: current and emerging uses.
    Agosta F; Spinelli EG; Filippi M
    Expert Rev Neurother; 2018 May; 18(5):395-406. PubMed ID: 29630421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS biomarkers for therapy development: State of the field and future directions.
    Benatar M; Boylan K; Jeromin A; Rutkove SB; Berry J; Atassi N; Bruijn L
    Muscle Nerve; 2016 Feb; 53(2):169-82. PubMed ID: 26574709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomics and Metabolomics in Amyotrophic Lateral Sclerosis.
    Krokidis MG
    Adv Exp Med Biol; 2020; 1195():205-212. PubMed ID: 32468479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
    Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
    JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarkers for amyotrophic lateral sclerosis].
    Tokuda T
    Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging molecular biomarker targets for amyotrophic lateral sclerosis.
    Costa J; de Carvalho M
    Clin Chim Acta; 2016 Apr; 455():7-14. PubMed ID: 26774696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in Neurodegenerative Diseases.
    Jeromin A; Bowser R
    Adv Neurobiol; 2017; 15():491-528. PubMed ID: 28674995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging in amyotrophic lateral sclerosis: MRI and PET.
    Kassubek J; Pagani M
    Curr Opin Neurol; 2019 Oct; 32(5):740-746. PubMed ID: 31335337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing mechanistic understanding and biomarker development in amyotrophic lateral sclerosis.
    Thompson AG; Oeckl P; Feneberg E; Bowser R; Otto M; Fischer R; Kessler B; Turner MR
    Expert Rev Proteomics; 2021 Nov; 18(11):977-994. PubMed ID: 34758687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein biomarkers for amyotrophic lateral sclerosis.
    Ryberg H; Bowser R
    Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A prognostic biomarker in amyotrophic lateral sclerosis].
    Mitsumoto H; Saito T
    Rinsho Shinkeigaku; 2018 Dec; 58(12):729-736. PubMed ID: 30487362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.